Clinical Therapeutics (@clinthe) header
Clinical Therapeutics (@clinthe) profile picture

The International Peer-Reviewed Journal of Drug Therapy Supports Open Access Opinions are the editorial team鈥檚.

Philadelphia, US & Oxford, UK
Joined September 2011
Clinical Therapeutics retweeted
Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, a new study in @TheLancetOncol suggests hubs.li/Q02cGh2Q0
8
270
52
381
236,250
Clinical Therapeutics retweeted
#Cannabis is at the forefront of the scientific and policy discussion in modern medicine. In a special issue of @clinthe, experts shed light on its complexities and therapeutic potential: spkl.io/60104i3AC #SciencePolicy #CannabisMedicine
2
1
5
2,961
Clinical Therapeutics retweeted
馃毃There will be a special issue in 饾棖饾椆饾椂饾椈饾椂饾棸饾棶饾椆 饾棫饾椀饾棽饾椏饾棶饾椊饾棽饾槀饾榿饾椂饾棸饾榾 @clinthe dedicated to #PsoriaticArthritis, featuring a star-studded cast of amazing authors. Join them by submitting your papers! DM open for any questions @GrappaO @BritPact @britspauk
1
3
10
1,428
Clinical Therapeutics retweeted
The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World dlvr.it/RwBkTh
1
1
Clinical Therapeutics retweeted
How Health Care Systems Can Advance Therapeutics dlvr.it/Rw90tK
2
3
Clinical Therapeutics retweeted
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic dlvr.it/Rvzswp
2
1
Clinical Therapeutics retweeted
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency dlvr.it/RvwDYc
1
1
Clinical Therapeutics retweeted
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice dlvr.it/RvJRvS
Clinical Therapeutics retweeted
Value of Growth/Differentiation Factor 15 in Diagnosis and the Evaluation of Chemotherapeutic Response in Lung Cancer dlvr.it/Rv920H
Clinical Therapeutics retweeted
Once-Daily SPN-812聽200 and 400聽mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial dlvr.it/Rv6NV7
Clinical Therapeutics retweeted
Anesthesia and the Developing Brain: A Review of Sevoflurane-induced Neurotoxicity in Pediatric Populations dlvr.it/Rtqp4d
Clinical Therapeutics retweeted
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial dlvr.it/RtdN94
Clinical Therapeutics retweeted
Inpatient omission of ACEi and ARBs is associated with morbidity and mortality in COVID-19 dlvr.it/RtT7Nf
Clinical Therapeutics retweeted
Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects dlvr.it/RtLHhr
Clinical Therapeutics retweeted
Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018 dlvr.it/RtLHf8
Clinical Therapeutics retweeted
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults dlvr.it/RtG9C2
Clinical Therapeutics retweeted
In response to Du et聽al., 2020, 42(9):1799-1810 dlvr.it/RtBKs0
Clinical Therapeutics retweeted
Nonalcoholic Fatty Liver Disease: Epidemiology, Assessments, and Interventions Entering 2021 dlvr.it/Rt4bLD
Clinical Therapeutics retweeted
Ethical and Regulatory Considerations of Placental Therapeutics dlvr.it/Rt0lwh
Clinical Therapeutics retweeted
Table of Contents dlvr.it/RsxKjj